$REGN Recent News Nasdaq falls for 4th day in row; Dow,

New Post Public Reply Private Reply Replies (0) Message Board

Mar 14, 2014 at 12:52 PM

$REGN Recent News

Nasdaq falls for 4th day in row; Dow, S&P slip for 2nd day: stock market live blog recap 3:51 p.m. March 11, 2014 - blogs.marketwatch.com
Bull market’s biggest winners and losers 7:00 a.m. March 10, 2014 - Jeff Reeves
Lorillard and Reynolds jump on buyout report 5:16 p.m. March 3, 2014 - Sue Chang
Sprint gains on narrower loss; WPX tops S&P 500 losers 5:15 p.m. Feb. 11, 2014 - Sue Chang
Dow nabs best gain of year after Yellen remarks, debt-ceiling news: stock market live blog recap 4:55 p.m. Feb. 11, 2014 - blogs.marketwatch.com
Regeneron diabetic eye remedy does well in trial 9:02 a.m. Feb. 10, 2014 - MarketWatch.com
Stocks stabilize; now it’s up to Yellen, the consumer 9:01 a.m. Feb. 9, 2014 - Wallace Witkowski
Tesla extends gains; ExOne sinks on revenue warning 4:45 p.m. Jan. 15, 2014 - Sue Chang
GameStop tumbles 20%; Tesla surges on strong sales 5:23 p.m. Jan. 14, 2014 - Sue Chang
Regeneron climbs by double-digits, leads S&P after presentation 4:58 p.m. Jan. 14, 2014 - Russ Britt
Dow jumps 116 points, best day this year: Stock market live blog recap 4:51 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Three biopharma companies poised for product OKs in 2014: analyst 1:51 p.m. Jan. 6, 2014 - Russ Britt
Goldman's biotech downgrade and the new consensus 12:53 p.m. Jan. 6, 2014 - MarketWatch.com
Apple off on market data, Twitter down as options debut 5:36 p.m. Nov. 15, 2013 - Sue Chang
Macy's, Potbelly gain; Chegg slumps in debut 6:04 p.m. Nov. 13, 2013 - Sue Chang
GT spikes on sapphire deal with Apple 5:45 p.m. Nov. 5, 2013 - Sue Chang
Regeneron shares near $300 as earnings report emboldens investors 12:14 p.m. Nov. 5, 2013 - Russ Britt
The next big pharma 7:01 a.m. Oct. 25, 2013 - The Trading Deck
Apple extends gains on price target hike 3:47 p.m. Oct. 16, 2013 - Sue Chang
Apple gains on upgrade; BlackBerry rallies 4:34 p.m. Oct. 7, 2013 - Sue Chang

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100 8:00 a.m. March 13, 2014 - 247WallSt.com
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
Next Stop for the Nasdaq: 5000 3:33 a.m. March 8, 2014 - Barrons.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:17 p.m. March 7, 2014 - TheStreet.com
FDA Advises of Adverse Effects from New Cholesterol Drugs 6:08 p.m. March 7, 2014 - The Wall Street Journal Interactive Edition
Regeneron and Sanofi to look into side effects of cholesterol drug candidate 4:24 p.m. March 7, 2014 - Seeking Alpha
3 Stocks Reiterated As A Hold: FCX, TSLA, REGN 3:01 p.m. March 7, 2014 - TheStreet.com
Water-Logged And Getting Wetter: Regeneron Pharmaceuticals (REGN) 1:17 p.m. March 7, 2014 - TheStreet.com
Regeneron Cholesterol-Drug Worries Ding Stock 1:11 p.m. March 7, 2014 - Investors Business Daily
Insider Trading Alert - CNW, PPS And REGN Traded By Insiders 11:45 a.m. March 6, 2014 - TheStreet.com
10 Best Stocks Since the Bull Market Began 10:15 a.m. March 6, 2014 - InvestorPlace.com
Update on Bayer/Regeneron's Eylea - Analyst Blog 4:55 p.m. March 5, 2014 - Zacks.com
Regeneron Pharmaceuticals (REGN) Hits New Lifetime High Today 9:45 a.m. March 5, 2014 - TheStreet.com
Cramer's Mad Money - 5 Putin-Proof Sectors (3/4/14) 6:13 a.m. March 5, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Stocks on Sale 8:08 p.m. March 4, 2014 - TheStreet.com
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Winner 5:00 p.m. March 3, 2014 - TheStreet.com
Regeneron announces regulatory submission in Japan 10:20 a.m. March 3, 2014 - Seeking Alpha
Bayer: Xarelto and Eylea to reach peak revenues in 5-6 years 7:37 a.m. Feb. 28, 2014 - Seeking Alpha
Regeneron Pipeline Could Be The Big Story In 2014 5:30 p.m. Feb. 27, 2014 - Investors Business Daily
Biotech Stock Roundup: Isis Soars on Positive Data, Onconova Falls - Analyst Blog 10:26 a.m. Feb. 26, 2014 - Zacks.com

Marketing Authorization Applications, Quarterly Dividends, Publication of Clinical Trial Data, Acquisitions, and Financial Results - Analyst Notes on Regeneron, Amgen, Sangamo, Alnylam, and Agios 9:08 a.m. March 11, 2014 - PR Newswire - PRF
Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare 11:50 a.m. March 6, 2014 - PR Newswire - PRF
Bayer HealthCare and Regeneron Announce Regulatory Submission of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Japan 2:00 a.m. March 3, 2014 - PR Newswire - PRF
Critical Alerts For Walter Energy, Regeneron, Biogen Idec, Red Hat, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for the Treatment of Macular Edema Following Branch Retinal Vein Occlusion 7:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
Regeneron Announces Upcoming 2014 Investor Conference Presentations 9:30 a.m. Feb. 14, 2014 - PR Newswire - PRF
Regeneron Reports Fourth Quarter and Full Year 2013 Financial and Operating Results 6:30 a.m. Feb. 11, 2014 - PR Newswire - PRF
Two-Year Results From Phase 3 VISTA Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision 7:30 a.m. Feb. 10, 2014 - PR Newswire - PRF
Critical Alerts For Intel, Regeneron, Lowes, eBay, and KB Homes Released By InvestorsObserver 9:31 a.m. Jan. 23, 2014 - PR Newswire - PRF
Regeneron to Report Fourth Quarter and Full Year 2013 Financial and Operating Results and Host Conference Call and Webcast on February 11, 2014 9:30 a.m. Jan. 21, 2014 - PR Newswire - PRF
Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration 4:05 p.m. Jan. 13, 2014 - PR Newswire - PRF
Regeneron and Geisinger Health System Announce Major Human Genetics Research Collaboration 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Regeneron Launches New Human Genetics Initiative 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Regeneron Announces Amendment to Investor Agreement with Sanofi 2:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 8:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Critical Alerts For Stratasys, Regeneron, Ctrip, Paychex, and Tyson Released By InvestorsObserver 9:31 a.m. Dec. 23, 2013 - PR Newswire
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals 8:00 a.m. Dec. 19, 2013 - PR Newswire
Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program 1:00 a.m. Dec. 19, 2013 - PR Newswire
Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication 7:30 a.m. Dec. 18, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

American Savings Bank IPO Hits NYSE: $129M Raised

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Lyric Health's AI System Promises Data-Driven Revolution

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

2026 CEE Awards Highlight Energy Innovation Leaders

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Solar Fencing Revolutionizes North Texas Homes

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Red Banyan Earns Top Honors in Florida for 2026

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Goddess Maintenance Co. Eyes BeautyMatter Award

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Finastra Recognized as 2026 Leader in Payment Platforms

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

ScholarShare 529 Launches $50 Back-to-School Promo

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

B2B Growth Hinges on Narrative Coherence, Study Shows

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....